Russell Investments Group Ltd. decreased its stake in shares of Intersect ENT, Inc. (NASDAQ:XENT – Get Score) by 39.2% in the course of the first quarter, Holdings Channel studies. The agency owned 19,749 shares of the medical tools supplier’s inventory after promoting 12,738 shares in the course of the quarter. Russell Investments Group Ltd.’s holdings in Intersect ENT have been value $553,000 as of its most up-to-date submitting with the Securities & Trade Fee.

A lot of different hedge funds and different institutional traders additionally lately added to or decreased their stakes within the inventory. Versor Investments LP lifted its place in Intersect ENT by 4.7% in the course of the first quarter. Versor Investments LP now owns 3,323,482 shares of the medical tools supplier’s inventory valued at $93,091,000 after buying a further 148,385 shares in the course of the interval. Alpine Associates Administration Inc. lifted its place in Intersect ENT by 1.6% in the course of the fourth quarter. Alpine Associates Administration Inc. now owns 1,414,600 shares of the medical tools supplier’s inventory valued at $38,635,000 after buying a further 21,600 shares in the course of the interval. Nuance Investments LLC lifted its place in Intersect ENT by 23.1% in the course of the fourth quarter. Nuance Investments LLC now owns 576,992 shares of the medical tools supplier’s inventory valued at $15,758,000 after buying a further 108,438 shares in the course of the interval. Alliancebernstein L.P. lifted its place in Intersect ENT by 2.2% in the course of the fourth quarter. Alliancebernstein L.P. now owns 518,678 shares of the medical tools supplier’s inventory valued at $14,165,000 after buying a further 11,240 shares in the course of the interval. Lastly, Financial institution of America Corp DE lifted its place in Intersect ENT by 95.2% in the course of the fourth quarter. Financial institution of America Corp DE now owns 515,880 shares of the medical tools supplier’s inventory valued at $14,089,000 after buying a further 251,593 shares in the course of the interval. Institutional traders personal 92.47% of the corporate’s inventory.

Intersect ENT Value Efficiency

XENT inventory opened at $28.24 on Monday. Intersect ENT, Inc. has a 52 week low of $15.92 and a 52 week excessive of $28.25. The corporate has a fast ratio of 1.50, a present ratio of 1.88 and a debt-to-equity ratio of 6.89. The corporate has a fifty day easy transferring common of $28.24 and a two-hundred day easy transferring common of $27.95. The agency has a market capitalization of $954.91 million, a P/E ratio of -5.90 and a beta of 1.45.

Analysts Set New Value Targets

Individually, StockNews.com began protection on shares of Intersect ENT in a analysis report on Sunday. They issued a “promote” score on the inventory.

Intersect ENT Profile

(Get Score)

Intersect ENT, Inc operates as an ear, nostril, and throat (ENT) medical know-how firm in america. The corporate provides PROPEL, a steroid releasing implant to open the surgically enlarged sinus; PROPEL Mini, a releasing implant to deal with sufferers present process frontal sinus surgical procedure; and PROPEL Contour, a steroid releasing implant for the therapy of frontal and maxillary sinus ostia, or openings, of the dependent sinuses.

See Additionally

Wish to see what different hedge funds are holding XENT? Go to HoldingsChannel.com to get the most recent 13F filings and insider trades for Intersect ENT, Inc. (NASDAQ:XENT – Get Score).

Obtain Information & Rankings for Intersect ENT Each day – Enter your e-mail handle beneath to obtain a concise every day abstract of the most recent information and analysts’ rankings for Intersect ENT and associated firms with MarketBeat.com’s FREE every day e-mail e-newsletter.